How severe is CVE-2024-34399?

CVE-2024-34399 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2024-34399 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (40th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2024-34399?

CVE-2024-34399 affects Bmc Remedy Mid-tier. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2024-34399?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.

Does CVE-2024-34399 have an EU (EUVD) identifier?

Yes. CVE-2024-34399 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-34764.

When was CVE-2024-34399 published?

CVE-2024-34399 was published on 2024-09-18 and last updated on 2026-06-17.

CVE-2024-34399

CVE-2024-34399 is a critical-severity vulnerability in Bmc Remedy Mid-tier with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-287.

Key facts

Severity: Critical (CVSS 3.x base score 9.8)
EPSS exploit prediction: 1% (40th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-34764
Weakness: CWE-287
Affected product: Bmc Remedy Mid-tier
Published: 2024-09-18
Last modified: 2026-06-17

Description

**UNSUPPORTED WHEN ASSIGNED** An issue was discovered in BMC Remedy Mid Tier 7.6.04. An unauthenticated remote attacker is able to access any user account without using any password. NOTE: This vulnerability only affects products that are no longer supported by the maintainer and the impacted version for this vulnerability is 7.6.04 only.

Frequently asked questions

What is CVE-2024-34399?: **UNSUPPORTED WHEN ASSIGNED** An issue was discovered in BMC Remedy Mid Tier 7.6.04. An unauthenticated remote attacker is able to access any user account without using any password. NOTE: This vulnerability only affects products that are no longer supported by the maintainer and the impacted version for this vulnerability is 7.6.04 only.
How severe is CVE-2024-34399?: CVE-2024-34399 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2024-34399 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (40th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-34399?: CVE-2024-34399 affects Bmc Remedy Mid-tier. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-34399?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
Does CVE-2024-34399 have an EU (EUVD) identifier?: Yes. CVE-2024-34399 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-34764.
When was CVE-2024-34399 published?: CVE-2024-34399 was published on 2024-09-18 and last updated on 2026-06-17.

References

https://www.gruppotim.it/it/footer/red-team.html

Affected products (1)

cpe:2.3:a:bmc:remedy_mid-tier:7.6.04:*:*:*:*:*:*:*

More vulnerabilities in Bmc Remedy Mid-tier

CVE-2017-17674 — Critical (CVSS 9.8): BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on what can…
CVE-2017-17677 — High (CVSS 8.8): BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create…
CVE-2018-18862 — High (CVSS 8.8): BMC Remedy Mid-Tier 7.1.00 and 9.1.02.003 for BMC Remedy AR System has Incorrect Access Control in ITAM forms, as…
CVE-2017-17678 — Medium (CVSS 6.1): BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability…
CVE-2017-17675 — Medium (CVSS 5.3): BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. Remote logging can be accessed by unauthenticated users,…
CVE-2024-34398 — Medium (CVSS 4.2): An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by…

All CVEs affecting Bmc Remedy Mid-tier →

Other CWE-287 (Improper Authentication) vulnerabilities

CVE-2026-45480 — Critical (CVSS 10.0): Improper authentication in Azure Active Directory allows an unauthorized attacker to elevate privileges over a network.
CVE-2026-46389 — Critical (CVSS 10.0): UDS Identity Config builds the Keycloak configuration image (realm, plugins, theme, truststore, JARs) consumed by UDS…
CVE-2026-10611 — Critical (CVSS 10.0): An authentication bypass vulnerability exists in MISP when LDAP mixed authentication is enabled with OTP enforcement.…
CVE-2026-47280 — Critical (CVSS 10.0): Improper authentication in Azure Resource Manager (ARM) allows an unauthorized attacker to elevate privileges over a…
CVE-2026-42822 — Critical (CVSS 10.0): Improper authentication in Azure Local Disconnected Operations allows an unauthorized attacker to elevate privileges…
CVE-2026-20182 — Critical (CVSS 10.0): May 2026: This security advisory provides the details and fix information for a vulnerability that was discovered and…

Browse all CWE-287 (Improper Authentication) vulnerabilities →